Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Case Pushes U.S. Health Settlements to $6.6 Billion
Bloomberg
Thursday, September 27, 2012 - 10:36am
tags:
GSK, settlements, Paxil, Wellbutrin
2 Shrinking Biotech Companies
Motley Fool
Thursday, September 27, 2012 - 10:29am
tags:
Sanofi, Dendreon
A.P. Pharma: New Board Member Brings Great Expertise To Possible Launch Of APF530
Seeking Alpha
Thursday, September 27, 2012 - 10:29am
tags:
AP Pharma, Sanofi, APF530
Protalix receives marketing authorization for Elelyso from Israel
Yahoo/Fly on the Wall
Thursday, September 27, 2012 - 10:27am
tags:
Protalix, Elelyso, Israel, Gaucher disease
FDA to decide by March on Pfizer/Bristol blood thinner
Reuters
Wednesday, September 26, 2012 - 10:04pm
tags:
FDA, Pfizer, Bristol-Myers Squibb, bloodthinners, Eliquis
Merck Returns To Cardiome All Rights To Atrial Fibrillation Drug Vernakalant
Forbes
Wednesday, September 26, 2012 - 10:02pm
tags:
Merck, Cardiome, Vernakalant, atrial fibrillation
PsiOxus Starts Human Tests of Cancer Vaccine
Bloomberg
Wednesday, September 26, 2012 - 12:21pm
tags:
PsiOxus, vaccines, GSK, cancer, ColoAd1
NuPathe drops 27% after raising $28M in private placement
Yahoo/Fly the on Wall
Wednesday, September 26, 2012 - 12:18pm
tags:
NuPathe
AstraZeneca builds virtual neuroscience drug unit byte by byte
Fierce Biotech IT
Wednesday, September 26, 2012 - 12:15pm
tags:
AstraZeneca, R&D
Where is Ranbaxy's copycat version of Diovan?
Fierce Pharma
Wednesday, September 26, 2012 - 12:13pm
tags:
generics, Diovan, Novartis, Ranbaxy, antihypertensives
Spectrum Pharmaceuticals Trying to Put the Cat Back in the Bag
Motley Fool
Wednesday, September 26, 2012 - 12:07pm
tags:
Spectrum Pharmaceuticals, TopoTarget, belinostat, peripheral T-cell lymphoma
FDA Wants To Speed Drugs To Market: We've Heard That Before
Forbes
Wednesday, September 26, 2012 - 12:03pm
tags:
FDA, drug approvals
Health by the Numbers shows the research-based pharmaceutical industry ‘walks the talk’ on health prevention and prioritizes employees’ health
CP Wire
Wednesday, September 26, 2012 - 12:01pm
tags:
pharma industry, pharma employees
Mallinckrodt acquiring CNS Therapeutics for $100 million in cash
Star Tribune, MN
Wednesday, September 26, 2012 - 11:16am
tags:
M&A, CNS Therapeutics, Mallinckrodt
FDA Gets New Authority Over Clinical Trial Reporting
Pharmalot
Wednesday, September 26, 2012 - 11:15am
tags:
FDA, clinical trials
Lymphoseek: No Quick Approval Here
Motley Fool
Wednesday, September 26, 2012 - 11:13am
tags:
Lymphoseek, Navidea Biopharmaceuticals
Sucampo Pharmaceuticals shares continue climb after FDA agrees to faster drug review
Yahoo/AP
Wednesday, September 26, 2012 - 11:12am
tags:
Amitiza, Sucampo, FDA, opiod-induced constipation
Are Allergan's Numbers Better Than They Look?
Motley Fool
Wednesday, September 26, 2012 - 11:10am
tags:
Allergan
Are Big Pharma Investors Ignoring the Patent Cliff?
Motley Fool
Wednesday, September 26, 2012 - 11:01am
tags:
patents, patent cliff, Abbott Labs, Merck, Eli Lilly, Pfizer
Biogen's New Hemophilia Drug Could Replace Pfizer's Old One
Forbes
Wednesday, September 26, 2012 - 11:00am
tags:
hemophilia, Pfizer, BiogenIdec, factor IX, BeneFix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.